<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Infect Dis Obstet Gynecol</journal-id><journal-title>Infectious Diseases in Obstetrics and Gynecology</journal-title><issn pub-type="ppub">1064-7449</issn><issn pub-type="epub">1098-0997</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">11368263</article-id><article-id pub-id-type="pmc">1784633</article-id>
            <article-id pub-id-type="pii">S1064744901000035</article-id>
            <article-id pub-id-type="doi">10.1155/S1064744901000035</article-id>
      <article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Efficacy of Clindamycin Vaginal Ovule (3-Day Treatment) vs.
Clindamycin Vaginal Cream (7-Day Treatment) in Bacterial Vaginosis</article-title></title-group><contrib-group>
            <contrib contrib-type="author" corresp="yes"><name><surname>Sobel</surname><given-names>Jack</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib>
            <contrib contrib-type="author"><name><surname>Peipert</surname><given-names>Jeffrey F.</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib>
            <contrib contrib-type="author"><name><surname>McGregor</surname><given-names>James A.</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib>
            <contrib contrib-type="author"><name><surname>Livengood</surname><given-names>Charles</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib>
            <contrib contrib-type="author"><name><surname>Martin</surname><given-names>Maureen</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib>
            <contrib contrib-type="author"><name><surname>Robbins</surname><given-names>Jill</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib>
            <contrib contrib-type="author"><name><surname>Wajszczuk</surname><given-names>Charles P.</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib>
      </contrib-group>
    <aff id="aff1"><label>1</label>
<addr-line>Division of Infectious Diseases</addr-line>
<addr-line>Detroit Medical Center</addr-line>
<addr-line>Wayne State University School of
Medicine</addr-line>
<addr-line>3990 John R. Street</addr-line>
<addr-line>Detroit</addr-line>
<addr-line>MI</addr-line>
<addr-line>48201</addr-line>
<country>USA</country>
</aff>
<aff id="aff2"><label>2</label>
<addr-line>Women and Infants Hospital</addr-line>
<addr-line>Brown University School of Medicine</addr-line>
<addr-line>Providence</addr-line>
<addr-line>RI</addr-line>
<country>USA</country>
</aff>
<aff id="aff3"><label>3</label>
<addr-line>Denver Health Medical Center</addr-line>
<addr-line>Denver</addr-line>
<addr-line>CO</addr-line>
<country>USA</country>
</aff>
<aff id="aff4"><label>4</label>
<addr-line>Duke University Medical Center</addr-line>
<addr-line>Durham</addr-line>
<addr-line>NC</addr-line>
<country>USA</country>
</aff>
<aff id="aff5"><label>5</label>
<addr-line>Pharmacia and Upjohn</addr-line>
<addr-line>Kalamazoo</addr-line>
<addr-line>MI</addr-line>
<country>USA</country>
</aff>
      <pub-date pub-type="ppub"><year>2001</year></pub-date><volume>9</volume><issue>1</issue><fpage>9</fpage><lpage>15</lpage><history><date date-type="received"><day>1</day><month>12</month><year>1999</year></date><date date-type="accepted"><day>30</day><month>11</month><year>2000</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2001 Hindawi Publishing Corporation.</copyright-statement><copyright-year>2001</copyright-year><copyright-holder>Hindawi Publishing Corporation</copyright-holder><license license-type="open-access" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by/"><p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract>
<p><italic>Objective:</italic> To compare the efficacy and safety of a 3-day regimen of clindamycin vaginal ovules with a 7-day
regimen of clindamycin vaginal cream for the treatment of bacterial vaginosis (BV)</p>
<p><italic>Methods:</italic> Women with a clinical diagnosis of BV were treated with a 3-day course of clindamycin ovules or a 7-day
course of clindamycin cream administered intravaginally. Three hundred and eighty-four patients received study
drug and were included in the evaluable patient population (ovule group, <italic>n</italic> = 204; cream group, <italic>n</italic> = 180).
Assessments included pelvic examination and diagnostic testing. Primary efficacy endpoints were a resolution of
two of three diagnostic criteria at the first follow-up visit and three of three diagnostic criteria at the second.</p>
<p><italic>Results:</italic> Cure rates in the evaluable patient population were similar between treatment groups: 53.7% (109/204)
for the ovule group and 47.8% (85/180) for the cream group (<italic>p</italic> = 0.2471, 95% CI&#x02013; 4.1&#x02013;16.0%). The most
commonly reported medical event, vulvovaginal pruritus, had similar incidence in both treatment groups.</p>
<p><italic>Conclusions:</italic> A 3-day course of clindamycin vaginal ovules is as effective and well-tolerated as a 7-day course of
clindamycin vaginal cream in the treatment of BV.</p>
</abstract></article-meta></front></article>


